12:00 AM
Oct 11, 2004
 |  BC Week In Review  |  Clinical News  |  Clinical Status

MG98: Phase II start

MYG began a 2-step Phase II trial of MG98 plus interferon alpha. The first step will evaluate the safety, pharmacokinetics and optimal dosing of the combination therapy in...

Read the full 119 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >